[IR-H-(C2H4)[KAPA(2)-(C,O)-CH=CHC(ET)=O]-(PPH3)2]-CLO4
Compound with spectra: 1 NMR
![[IR-H-(C2H4)[KAPA(2)-(C,O)-CH=CHC(ET)=O]-(PPH3)2]-CLO4](/api/compound/6NYFuT7xnOq.png?ph=true&h=300&w=458 "[IR-H-(C2H4)[KAPA(2)-(C,O)-CH=CHC(ET)=O]-(PPH3)2]-CLO4")
| SpectraBase Compound ID | 6NYFuT7xnOq |
|---|---|
| InChI | InChI=1S/2C18H15P.C5H7O.C2H2.ClHO4.Ir.H/c2*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-3-5(6)4-2;1-2;2-1(3,4)5;;/h2*1-15H;1,3H,4H2,2H3;1-2H;(H,2,3,4,5);;/q;;;;;-1;/p+1 |
| InChIKey | CNRCTRJWITTXSZ-UHFFFAOYSA-O |
| Mol Weight | 928.4 g/mol |
| Molecular Formula | C43H42ClIrO5P2 |
| Exact Mass | 928.182525 g/mol |
| Parent InChIKey | IWLRSSPOIOCJHQ-UHFFFAOYSA-O |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
IR-H-(CL)[KAPA(2)-(C,O)-C(OME)=CHC(ME)=O]-(PPH3)2
JWH-081 N-(4-hydroxypentyl) metabolite
JWH-081 N-(5-hydroxypentyl) metabolite
KANDENOL_C;7-EPI-5-HYDROPEROXY-8,11-DIHYDROXY-3-EUDESMEN-2-ONE
JWH-082
[1-(5-FLUOROPENTYL)-1H-INDOL-3-YL]-(4-METHOXYNAPHTHALEN-1-YL)-METHANONE;AM-2201-4-METHOXYNAPHTHYL-ANALOG;4-MEO-AM-2201
JWH 081
1H-Indene-4-carboxylic acid, octahydro-5-(2-hydroxy-4-methoxyphenyl)-7a-methyl-1-oxo-, (3a.alpha.,4.beta.,5.beta.,7a.beta.)-(.+-.)-
5-(2'-HYDROXY-4'-METHOXYPHENYL)-7A-BETA-METHYL-1-OXO-2,3,3A-ALPHA,4,5,6,7,7A-OCTAHYDRO-1H-INDENE-4-ZETA-CARBOXYLIC-ACID
2-BENZYL-4,6-DIHYDROXY-BENZOIC-ACID-6-O-(3,6-O-DIACETYL)-BETA-D-GLUCOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| Preparation of hydrido(vinyl)iridium(III) complexes from functionalized olefins by CH activation | Canadian Journal of Chemistry | 2006 |